HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John K McCormick Selected Research

Staphylococcal enterotoxin F

10/2019Regulation of toxic shock syndrome toxin-1 by the accessory gene regulator in Staphylococcus aureus is mediated by the repressor of toxins.
3/2013Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.
2/2011Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.
10/2003Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John K McCormick Research Topics

Disease

20Septic Shock (Toxic Shock Syndrome)
01/2021 - 02/2002
10Infections
01/2019 - 06/2009
6Endocarditis
01/2020 - 04/2002
5Bacteremia
01/2022 - 09/2014
4Scarlet Fever
12/2021 - 05/2014
4Cytokine Release Syndrome
12/2019 - 01/2017
3Sepsis (Septicemia)
01/2022 - 01/2015
2Shock
12/2019 - 01/2012
1Communicable Diseases (Infectious Diseases)
12/2021
1COVID-19 related pediatric multisystem inflammatory disease
01/2021
1COVID-19
01/2021
1Superinfection
01/2020
1Human Influenza (Influenza)
01/2020
1Asymptomatic Infections
01/2019
1Pharyngitis (Sore Throat)
01/2018
1Rheumatic Heart Disease (Rheumatic Heart Diseases)
01/2018
1Gram-Positive Bacterial Infections
01/2017
1Abscess
09/2014
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2014
1Rheumatoid Arthritis
02/2014
1Psoriatic Arthritis
02/2014
1Colonic Neoplasms (Colon Cancer)
01/2014
1Neoplasms (Cancer)
01/2014
1Vaginitis
03/2013
1Bacterial Vaginosis
03/2013
1Inflammation (Inflammations)
01/2012
1Calculi (Calculus)
01/2004
1Urolithiasis
01/2004
1Rheumatic Fever (Acute Articular Rheumatism)
12/2002

Drug/Important Bio-Agent (IBA)

24SuperantigensIBA
01/2022 - 12/2002
4ExotoxinsIBA
10/2020 - 06/2009
4CytokinesIBA
12/2019 - 02/2007
4Staphylococcal enterotoxin FIBA
10/2019 - 10/2003
4Virulence Factors (Pathogenicity Factors)IBA
01/2019 - 02/2002
3Pharmaceutical PreparationsIBA
01/2019 - 10/2018
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2018 - 02/2007
3AntibodiesIBA
09/2017 - 04/2002
3Proteins (Proteins, Gene)FDA Link
02/2014 - 01/2004
2Interferon-gamma (Interferon, gamma)IBA
01/2022 - 09/2014
2HLA-DR4 Antigen (HLA DR4 Antigen)IBA
10/2020 - 09/2014
2EpitopesIBA
01/2020 - 02/2014
2Histocompatibility Antigens Class IIIBA
05/2018 - 05/2014
2staphylococcal enterotoxin BIBA
09/2017 - 06/2009
1Immunologic Factors (Immunomodulators)IBA
12/2021
1Deoxyribonucleases (DNase)FDA Link
10/2020
1ElementsIBA
01/2020
1DisulfidesIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2019
1Hydromorphone (Dilaudid)FDA LinkGeneric
01/2019
1Calcium-Sensing ReceptorsIBA
01/2018
1N- (2- hydroxy- 3- (2- cyano- 3- chlorophenoxy)propyl)- 1,1- dimethyl- 2- (2- nephthyl)ethylamineIBA
01/2018
1Streptococcus pyogenes SpeA proteinIBA
09/2017
1Immunoglobulins (Immunoglobulin)IBA
06/2017
1Mucin-3IBA
06/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1Antifungal AgentsIBA
12/2014
1ChemokinesIBA
09/2014
1Staphylococcal enterotoxin AIBA
09/2014
1Interleukin-12 (IL 12)IBA
09/2014
1ToxoidsIBA
05/2014
1Peptides (Polypeptides)IBA
02/2014
1Fibrinogen (Factor I)FDA Link
02/2014
1AntigensIBA
01/2014
1erythrogenic toxinIBA
01/2014
1Single-Chain AntibodiesIBA
01/2014
1LigandsIBA
06/2009
1Peptidoglycan (Murein)IBA
06/2009
1Toll-Like Receptor 2IBA
06/2009
1Biomarkers (Surrogate Marker)IBA
01/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2003
1DNA (Deoxyribonucleic Acid)IBA
04/2002
1FibrinIBA
04/2002
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2002
1Staphylococcus aureus RNAIIIIBA
02/2002

Therapy/Procedure

2Immunotherapy
01/2015 - 01/2014
1Therapeutics
06/2017
1Critical Care (Surgical Intensive Care)
01/2015
1Lasers (Laser)
01/2004